Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

Casinvent Pharma

Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.
2020
1-10
Brno, Jihomoravsky kraj, Czech Republic
  • Drug Discovery and Development
  • Oncology (Cancer)
  • Pharmaceuticals Packaging

Investment Funding

Last Funding Stage

Venture - Series Unknown

Total Funding Amount

3.03M

Last Funding Date

02-07-2025

Lead Investors

Dynumerics as, JIC Ventures, i&i Biotech Fund, Holecek Family Foundation, i&i Prague

Revenue

$1M to $10M

Something missing or incorrect on this page? Help us enrich this information